Stay updated with breaking news from Servatus Ltd. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
New Board appointment deepens and consolidates Servatus’ extensive commercial and scientific expertise for its global biotherapeutics programs Dr Buecheler joins...
Servatus Ltd. announced it has begun recruitment for its Phase I/II clinical trial for insomnia at the Sleep Disorders Centre at The Prince Charles
Study to look at the link between the gut microbiome and sleep, by treating patients who suffer from insomnia with...
Servatus Ltd's CEO Dr Wayne Finlayson discusses the company's recent $7.5 million capital raise to advance its live microbial and engineered...
Servatus has raised $7.5 million in an oversubscribed capital raise, with strong support from sophisticated shareholders Funds raised will underpin...